While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.

Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Private equity group CVC Capital ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

KKR & Co. is considering selling some of its controlling stake in JB Chemicals & Pharmaceuticals Ltd. via a block trade in ...

Incyte filed a lawsuit to try to block the launch of Leqselvi, claiming that the drug infringed a US patent (No. 9,662,335) ...

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...

A massive fire has broken out at a pharma company factory in Gujarat's Valsad. Several fire engines have been rushed to the ...

Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development ...